Growth Metrics

Labcorp Holdings (LH) Liabilities and Shareholders Equity (2016 - 2025)

Labcorp Holdings' Liabilities and Shareholders Equity history spans 17 years, with the latest figure at $18.4 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity changed 0.07% year-over-year to $18.4 billion; the TTM value through Dec 2025 reached $72.3 billion, up 106.09%, while the annual FY2025 figure was $18.4 billion, 0.07% changed from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $18.4 billion at Labcorp Holdings, up from $18.3 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $20.9 billion in Q3 2021 and bottomed at $16.7 billion in Q2 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $18.4 billion (2024), against an average of $18.8 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity rose 11.35% in 2021 before it dropped 17.02% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $20.4 billion in 2021, then dropped by 1.13% to $20.2 billion in 2022, then decreased by 17.02% to $16.7 billion in 2023, then rose by 9.89% to $18.4 billion in 2024, then grew by 0.07% to $18.4 billion in 2025.
  • Per Business Quant, the three most recent readings for LH's Liabilities and Shareholders Equity are $18.4 billion (Q4 2025), $18.3 billion (Q3 2025), and $18.1 billion (Q2 2025).